Join to View Full Profile
1536 N 115th StSeattle, WA 98133
Phone+1 206-668-5215
Fax+1 206-668-5214
Dr. Dash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I'm a Urologic Oncologist with expertise in laparoscopic, robotic and open surgery interested in academic positions.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2004 - 2007
University of MichiganResidency, Urology, 1998 - 2004- University of Michigan Health SystemInternship, Transitional Year, 1998 - 1999
University of Vermont College of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2007 - 2027
WA State Medical License 2013 - 2026
NY State Medical License 2004 - 2009
MI State Medical License 1998 - 2006
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:San Diego Area Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Chart Review of Laparoscopic Radical Cystectomy Start of enrollment: 2005 Dec 01
- Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy Start of enrollment: 2008 Oct 01
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance Study.Meera R Chappidi, Lisa F Newcomb, Yingye Zheng, Menghan Liu, Jeannette M Schenk
The Journal of Urology. 2025-09-01 - Prostate Cancer Imaging Stewardship: a multi-modal, physician-centered intervention for guideline-concordant imaging.Danil V Makarov, Jerry K Thomas, Shannon Ciprut, Adrian J Rivera, Scott E Sherman
Journal of the National Cancer Institute. 2025-08-11 - Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer:...Ruben Raychaudhuri, Ali Raza Khaki, Mary W Redman, Kelsey K Baker, Kevin Ng
European Urology. 2025-08-04
Journal Articles
- Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityMatthew R Cooperberg, Atreya Dash, JAMA Oncology
Authored Content
- Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityAugust 2020
- Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityAugust 2020
- Does the Diagnosis of Bladder Cancer Lead to Higher Rates of Smoking Cessation? Findings from the Medicare Health Outcomes SurveyMarch 2019
Press Mentions
Comorbidities Should Be Factor in Prostate Biopsy Choice, UCI Study FindsFebruary 10th, 2016
Professional Memberships
- Member
- Member
- Society of Urologic OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
